✦ LIBER ✦

The third analysis of the bicalutamide Early Prostate Cancer programme

✍ Scribed by PETER IVERSEN; on behalf of the Early Prostate Cancer programme investigators

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The bicalutamide Early Prostate Cancer P

✍ W.A. See; D. McLeod; P. Iversen; M. Wirth 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Immediate Therapy in Early Prostate Canc

✍ Manfred Wirth; Peter Iversen; David McLeod; William See 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Cost-Effectiveness Analysis of Bicalutam

✍ Karen Moeremans; Karin Caekelbergh; Lieven Annemans 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

The Prostate Cancer Continuum: The Role

✍ G. J. C. M. Kolvenbag 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB

182 Bicalutamide (‘Casodex’) 150 mg as a

✍ D. McLeod; P. Iversen; W. See; M. Wirth; K. Carroll; C. Morris; T. Morris 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Incidence of prostate cancer in Lithuani

✍ G. Smailyte; B. Aleknaviciene 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 177 KB